,GDG,question_id,included_article_id,included_postfulltext,included_reference,same_study_diff_article,notes,author_1_extract,year_pub_extract,author_year_format,included_article_doi,included_article_pmid,oa_id,ss_id,title_if_unavailable,id_sent_apiretrieval,title,publication_year,ids,referenced_works,referenced_works_count,type,cited_by_api_url,cited_by_count,topics,open_access,best_oa_location,biblio,primary_location,api_path,doi,pmid,mag_id,api_id_retrieved,abstract,apiid_match,original_index,citation_network_size,source_display_name,source_id,api_retrieval_success,paperId,externalIds,publicationVenue,year,referenceCount,citationCount,s2FieldsOfStudy,publicationTypes,journal,batch_ids,api_id_match,inluded_article_pmid,authors,doi.1,index,mesh_headings,pmid.1,url,venue,_merge_doi,_merge_pmid,alternate_title2,alternate_title3,author_address,best_match_index,best_match_string,custom1,custom2,custom3,custom4,doi_retrieved,doi_sent,end_page,file_attachments2,first_authors,issn,keywords,language,match_string,matching_title_from_embase_results,name_of_database,non_null_count,note,notes_abstract,number,place_published,pmid_retrieved,pmid_sent,primary_title,publisher,secondary_title,similarity_score,start_page,tertiary_title,type_of_reference,urls,volume
0,1,"1.5.1, 1.5.2",56,53,"Al-Jefout M, Alnawaiseh C, Saleh M, Warwar K. Anti-Müllerianhormone (AMH) new cutoff as a possible tool for thediagnosis of polycystic ovary syndrome (PCOS). J Biomed Sci Res. 2021;3(2):139. Doi: 10.36266/JBSR/139.",primary_citation,,Al-Jefout M,2021,"Al-Jefout M et al., 2021",,,,,,10.36266/jbsr/139,,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,1,1.12,277,60,"SIR-PETERMANN, T., VANTMAN, N., CONCHA, F., ECHIBURU, B., PEREIRA, C., DE GUEVARA, A. L., CRISOSTO, N. R., PEREZ-BRAVO, F. A. & SANTOS, J. L. 2014. Metabolic Profile and Eating Behavior Score in Prepubertal and Early Pubertal Sons of Women with Polycystic Ovary Syndrome. Endocr. Rev., 35, 2.",samestudy_276,,SIR-PETERMANN,2014,"SIR-PETERMANN et al., 2014",,,,,Metabolic Profile and Eating Behavior Score in Prepubertal and Early Pubertal Sons of Women with Polycystic Ovary Syndrome,no_id_provided,,,,,,,,,,,,,,,,,,,,,278.0,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2,1,1.12,282,60,"Leblanc, S. H., Leblanc, S., Battista, M. C., Geller, D. H., & Baillargeon, J. P. (2016). Evolution of metabolic alterations 5 years after peri-pubertal years in young girls genetically predisposed to polycystic ovary syndrome compared to age-matched control girls. Endocrine Reviews, 37(2 Supplement 1). doi:https://dx.doi.org/10.1210/endo-meetings.2016.RE.5.SUN-156",samestudy_281,,Leblanc,2016,"Leblanc et al., 2016",,,,,,10.1210/endo-meetings.2016.re.5.sun-156,,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
3,1,1.12,293,60,"Lenarcik, A., Bidzinska-Speichert, B. and Tworowska-Bardzinska, U. (2011) ‘Metabolic Abnormalities in Siblings of Women with Polycystic Ovary Syndrome’, ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 20(2), pp. 165–175. ",primary_citation,,Lenarcik,2011,"Lenarcik et al., 2011",,,,74019465.0,Metabolic Abnormalities in Siblings of Women with Polycystic Ovary Syndrome,no_id_provided,,,,,,,,,,,,,,,,,,,,,294.0,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
4,1,1.12,324,60,"TORCHEN, L., FOGEL, N. R., BRICKMAN, W., PAPARODIS, R. & DUNAIF, A. 2013. Persistent defects in pancreatic beta-cell function in early pubertal female relatives of women with polycystic ovary syndrome in a three year longitudinal study. Endocrine Reviews, 34.",samestudy_323,,TORCHEN,2013,"TORCHEN et al., 2013",,,,,Persistent defects in pancreatic beta-cell function in early pubertal female relatives of women with polycystic ovary syndrome in a three year longitudinal study,no_id_provided,,,,,,,,,,,,,,,,,,,,,325.0,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5,1,1.12,325,60,"TORCHEN, L. C., FOGEL, N. R., BRICKMAN, W. J., MAURAS, N. & DUNAIF, A. 2012. Beta-cell dysfunction and hyperandrogenemia in PCOS early pubertal female relatives. Endocrine Reviews, 33.",samestudy_323,,TORCHEN,2012,"TORCHEN et al., 2012",,,,,Beta-cell dysfunction and hyperandrogenemia in PCOS early pubertal female relatives,no_id_provided,,,,,,,,,,,,,,,,,,,,,326.0,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
6,2,2.2,432,80,"Ozenli, Y., Haydardedeoglu, B., Micozkadioglu, I., Simsek, E., Bulgan Kilicdag, E., & Bagis, T. (2008). Anxiety, Depression and Ways of Coping Skills by Women with Polycystic Ovary Syndrome: A Controlled Study. J Turkish-German Gynecol Assoc, 9(4), 190-194.",primary_citation,,Ozenli,2008,"Ozenli et al., 2008",,,,146131120.0,"Anxiety, Depression and Ways of Coping Skills by Women with Polycystic Ovary Syndrome: A Controlled Study",no_id_provided,,,,,,,,,,,,,,,,,,,,,433.0,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
7,2,2.6.1,503,41,"Arif N, Khawaja S, Iqbal Q. Awareness of Polycystic Ovarian Disease: Knowledge and Presence of Presenting Symptoms. Pakistan Journal of Medical and Health Sciences. 2020;14(2):627-30.",primary_citation,,Arif N,2020,"Arif N et al., 2020",,,,,Awareness of Polycystic Ovarian Disease: Knowledge and Presence of Presenting Symptoms,no_id_provided,,,,,,,,,,,,,,,,,,,,,504.0,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
8,3,3.1,592,18,"Nasrekani ZA, Fathi M. Efficacy of 12 weeks aerobic training on body composition, aerobic power and some women‐hormones in polycystic ovary syndrome infertile women. Iranian Journal of Obstetrics, Gynecology and Infertility 2016;19(5):1‐10.",primary_citation,prior search,Nasrekani ZA,2016,"Nasrekani ZA et al., 2016",,,,80790917.0,"Efficacy of 12 weeks aerobic training on body composition, aerobic power and some women‐hormones in polycystic ovary syndrome infertile women",no_id_provided,,,,,,,,,,,,,,,,,,,,,595.0,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
9,3,3.5,626,70,"Alipouri, B., Roohelhami, E., Shahrdami, F., & Rashidkhani, B. (2019). Dietary glycemic index/glycemic load and their relationship with inflammatory markers in women with polycystic ovary syndrome. PROGRESS IN NUTRITION, 21, 115-121.",primary_citation,,Alipouri,2019,"Alipouri et al., 2019",,,,,,10.23751/pn.v21i1-s.5616,,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
10,3,3.5,676,70,"Thara, C., & Divakar, S. U. M. A. (2017). Assessment of nutritional status of PCOS women in Kerala. International Journal of Applied Home Science, 4(9-10), 717-722.",primary_citation,,Thara,2017,"Thara et al., 2017",,,,,Serum level of anti‐mullerian hormone after exercise training in women with polycystic ovary syndrome: a randomised controlled trial,no_id_provided,,,,,,,,,,,,,,,,,,,,,680.0,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
11,4,4.2 / 4.3,702,85,"Aghamohammadzadeh N, Aliasgarzadeh A, Baglar L, Abdollahifard S, Bahrami A, Najafipour F, et al. Comparison of metformin and cyproteroneestrodiol compound effect on hs c-reactive protein and serum androgen levels in patients with poly cystic ovary syndrome. Pakistan journal of medical sciences. 2010;26(2):347-51.",primary_citation,,Aghamohammadzadeh N,2010,"Aghamohammadzadeh N et al., 2010",,,,54806151.0,Assessment of nutritional status of PCOS women in Kerala,no_id_provided,,,,,,,,,,,,,,,,,,,,,706.0,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
12,4,4.2 / 4.3,719,85,"Dorgham N, Sharobim A, Haggag H, El-Kalioby M, Dorgham D. Adding Combined Oral Contraceptives or Metformin to Laser Treatment in Polycystic Ovarian Syndrome Hirsute Patients. J Drugs Dermatol. 2021;20(3):302-6.",primary_citation,,Dorgham N,2021,"Dorgham N et al., 2021",,,,,,10.36849/jdd.2021.5652,,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
13,4,4.4,797,111,"Karimzadeh MA, Eftekhar M, Taheripanah R, Tayebi N, Sakhavat L, Zare F. The effect of administration of metformin on lipid profile changes and insulin resistance in patients with polycystic ovary syndrome. Middle East Fertil Soc J 2007 (ROB included in last TR under Tang 2012)",primary_citation,,Karimzadeh MA,2007,"Karimzadeh MA et al., 2007",,,,35054293.0,The effect of administration of metformin on lipid profile changes and insulin resistance in patients with polycystic ovary syndrome,no_id_provided,,,,,,,,,,,,,,,,,,,,,801.0,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
14,4,4.4,828,111,"Aghamohammadzadeh N, Aliasgarzadeh A, Baglar L, Abdollahifard S, Bahrami A, Najafipour F, et al. Pregnancy rate in women with pcos with high lh/fsh ratio undergoing icsi. Pakistan Journal of Medical Science 2010",primary_citation,,Aghamohammadzadeh N,2010,"Aghamohammadzadeh N et al., 2010",,,,54806151.0,The effect of administration of metformin on lipid profile changes and insulin resistance in patients with polycystic ovary syndrome,no_id_provided,,,,,,,,,,,,,,,,,,,,,832.0,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
15,4,4.8,972,8,"Dorgham, N.; Sharobim, A.; Haggag, H.; El-Kalioby, M.; Dorgham, D. (2021). Adding combined oral contraceptives or metformin to l aser treatment in polycystic ovarian syndrome hirsute patients.  Journal of drugs in dermatology: JDD 2021;20(3)302-306. Doi: 10.36849/JDD.2021.5652",primary_citation,,Dorgham,2021,"Dorgham et al., 2021",,,,,,10.36849/jdd.2021.5652,,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
16,5,5.1,1105,65,"Al Safi WG, Hassan MF. Pregnancy rate in women with pcos with high lh/fsh ratio undergoing icsi. Latin American Journal of Pharmacy. 2021;40(Special Issue):336-40.",primary_citation,,Al Safi WG,2021,"Al Safi WG et al., 2021",,,,,Pregnancy rate in women with pcos with high lh/fsh ratio undergoing icsi,no_id_provided,,,,,,,,,,,,,,,,,,,,,1109.0,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,1,1.6,108,47,"Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. Journal of Clinical Endocrinology & Metabolism. 2004;89(6):2745-2749. doi: 10.1210/jc.2003-032046",primary_citation,,Azziz R,2004,"Azziz R et al., 2004",,15181052.0,,,,pmid:15181052,,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2,1,1.6,114,47,"Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. Journal of Clinical Endocrinology & Metabolism. 1998;83(9):3078-3082. doi: 10.1210/jcem.83.9.5090",primary_citation,,Knochenhauer ES,1998,"Knochenhauer ES et al., 1998",,,,,,10.1210/jcem.83.9.5090,,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
3,1,1.6,119,47,"Deswal R, Dang AS, Nanda S. Prevalence of Poly Cystic Ovary Syndrome (PCOS) in North Indian women. Indian Journal of Health and Wellbeing. 2014;5(6):742-744.",primary_citation,,Deswal R,2014,"Deswal R et al., 2014",,,W2221924240,,Prevalence of Poly Cystic Ovary Syndrome (PCOS) in North Indian women,no_id_provided,,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
4,1,1.6,125,47,"Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. Journal of Clinical Endocrinology & Metabolism. 2000;85(7):2434-2438. doi: 10.1210/jcem.85.7.6682",primary_citation,,Asuncion M,2000,"Asuncion M et al., 2000",,,,,,10.1210/jcem.85.7.6682,,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5,1,1.6,138,47,"Salehpour S, Shirvani HE, Entezari A. Evaluation of the prevalence of polycystic ovarian syndrome among adolescent (15-18 years old) girls in Tehran during 2005-2006. International Journal of Fertility and Sterility. 2010;4(3):122-127.",primary_citation,,Salehpour S,2005,"Salehpour S et al., 2005",,,,,,10.22074/ijfs.2010.45808,,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
6,1,1.6,139,47,"Sharif E, Rahman S, Zia Y, Rizk NM. The frequency of polycystic ovary syndrome in young reproductive females in Qatar. Int J Womens Health. 2017;9:1-10. doi: 10.2147/IJWH.S120027",primary_citation,,Sharif E,2017,"Sharif E et al., 2017",,,,,,10.2147/ijwh.s120027,,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
7,1,1.9.1,234,18,"Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:1929–1935.",primary_citation,prior search,Apridonidze T,2005,"Apridonidze T et al., 2005",,15623819.0,,,,pmid:15623819,,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
10,1,1.12,311,60,"Sam S, Coviello AD, Sung YA, Legro RS, Dunaif A. Metabolic phenotype in the brothers of women with polycystic ovary syndrome. Diabetes Care. 2008 Jun;31(6):1237-41. doi: 10.2337/dc07-2190. Epub 2008 Mar 10. PMID: 18332151; PMCID: PMC2897239. (primary citation)",primary_citation,,Sam S,2008,"Sam S et al., 2008",,18332151.0,,,,pmid:18332151,,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
13,2,2.2,444,80,"Tseng PH, Chiu HM, Tu CH, Wu MS, Ho HN, Chen MJ. Obesity Exacerbates Irritable Bowel Syndrome-Related Sleep and Psychiatric Disorders in Women With Polycystic Ovary Syndrome. Front Endocrinol (Lausanne). 2021 Nov 16;12:779456. doi: 10.3389/fendo.2021.779456. PMID: 34867827; PMCID: PMC8635163.",primary_citation,,Tseng PH,2021,"Tseng PH et al., 2021",,34867827.0,,,,pmid:34867827,,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
15,3,3.1,596,18,"Saremi A, Nader, Karmali M, Kazemi M. Serum level of anti‐mullerian hormone after exercise training in women with polycystic ovary syndrome: a randomised controlled trial. Iranian Journal of Obstetrics, Gynecology and Infertility 2013;16(64):10.",primary_citation,prior search,Saremi A,2013,"Saremi A et al., 2013",,,W3121804787,, Serum level of anti‐mullerian hormone after exercise training in women with polycystic ovary syndrome: a randomised controlled trial.,no_id_provided,,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
18,4,4.7,953,29,"Khan, R.B., M. Sarosh, and S. Anwer. 2022. “Role of Myo-Inositol and D-Chiro-Inositol in Improvement of Endocrine and Clinical Parameters in Teenage Girls Affected by PCOS: A Prospective Cohort Study.” Pakistan Journal of Medical and Health Sciences 16 (1): 21–24. https://doi.org/10.53350/pjmhs2216121.
",primary_citation,,Khan,2022,"Khan et al., 2022",,,,,,10.53350/pjmhs2216121,,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
19,4,4.7,956,29,"Nehra, J., J. Kaushal, S.R. Singhal, and V.S. Ghalaut. 2017a. “A Comparative Study of Myo Inositol versus Metformin on Biochemical Profile in Polycystic Ovarian Syndrome in Women.” International Journal of Pharmaceutical Sciences and Research 8 (4): 1664–70. https://doi.org/10.13040/IJPSR.0975-8232.8(4).1664-70. (primary citation)",primary_citation,,Nehra,2017a,"Nehra et al., 2017a",,,,,,10.13040/ijpsr.0975-8232.8(4).1664-70,,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
21,5,5.4,1213,34,"Tang T, Glanville J, Hayden CJ, White D, Barth JH, Balen AH. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study. Hum Reprod. 2006 Jan;21(1):80-9. doi: 10.1093/humrep/dei311. Epub 2005 Sep 30 [Tang 2006b]",primary_citation,,Tang T,2006,"Tang T et al., 2006",,,,,,10.1093/humrep/dei311,,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1.2,3,16,"Imran H. J, Dhaher S. A, Mansour M. A. A. Testosterone or Dehydroepiandrosterone Sulfate as A Biomarker for Hirsutism in Women with Polycystic Ovary Syndrome. Biomed Pharmacol J 2020;13(4). DOI: https://dx.doi.org/10.13005/bpj/2056 ",primary_citation,,Imran H. J,2020,"Imran H. J et al., 2020",10.13005/bpj/2056,,,,,10.13005/bpj/2056,Salivary testosterone measurement in women with and without polycystic ovary syndrome,,,,,,,,,,,,,,10.13005/bpj/2056,,,,,,,,,,0,,,,,,,,,,,,,,,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,1,1.2,8,16,"Kumar H, Halder A, Sharma M, Jain M, Kalsi AK.Dihydrotestosterone- A Potential Biomarker of Hyperandrogenaemia in Polycystic Ovary Syndrome: A Case-control Study from North IndiaJ Clin of Diagn Res.2022; 16(2):QC09-QC14. https://www.doi.org/10.7860/JCDR/2022/51169.15962 ",primary_citation,,Kumar H,2022,"Kumar H et al., 2022",10.7860/JCDR/2022/51169.15962,,,246715314.0,,,A prospective study of anti‐mullerian hormone and other ovarian and adrenal hormones in adult female acne,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,7.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2,1,1.2,9,16,"Koskinen, P., T. A. Penttila, et al. (1996). ""Optimal use of hormone determinations in the biochemical diagnosis of the polycystic ovary syndrome."" Fertil Steril. 1996 Mar;65(3):517-22. doi: 10.1016/s0015-0282(16)58146-1",primary_citation,,Koskinen,1996,"Koskinen et al., 1996",10.1016/s0015-0282(16)58146-1,,,21873315.0,,,Testosterone or Dehydroepiandrosterone Sulfate as a Biomarker for Hirsutism in Women with Polycystic Ovary Syndrome,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,8.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
3,1,1.3,21,7,"Imran H. J, Dhaher S. A, Mansour M. A. A. Testosterone or Dehydroepiandrosterone Sulfate as A Biomarker for Hirsutism in Women with Polycystic Ovary Syndrome. Biomed Pharmacol J 2020;13(4).",primary_citation,,Imran H. J,2020,"Imran H. J et al., 2020",10.13005/bpj/2056,,,,,10.13005/bpj/2056,The Relevant Hormonal Levels and Diagnostic Features of Polycystic Ovary Syndrome in Adolescents,,,,,,,,,,,,,,10.13005/bpj/2056,,,,,,,,,,0,,,,,,,,,,,,,,,20.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
4,1,1.3,22,7,"Kumar, H., Halder, A., Sharma, M., Jain, M., & Kalsi, A. (2022). Dihydrotestosterone- A Potential Biomarker of Hyperandrogenaemia in Polycystic Ovary Syndrome: A Case-control Study from North India. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. doi: 10.7860/jcdr/2022/51169.15962",primary_citation,,Kumar,2022,"Kumar et al., 2022",10.7860/jcdr/2022/51169.15962,,,,,10.7860/jcdr/2022/51169.15962,Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS,,,,,,,,,,,,,,10.7860/jcdr/2022/51169.15962,,,,,,,,,,0,,,,,,,,,,,,,,,21.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5,1,"1.4.1, 1.4.2",38,27,"Fulghesu AM, Ciampelli M, Belosi C, Apa R, Pavone V, Lanzone A. A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: ovarian stroma/total area ratio. Fertil Steril 2001;76:326–331. DOI: 10.1016/s0015-0282(01)01919-7",primary_citation,,Fulghesu AM,2001,"Fulghesu AM et al., 2001",10.1016/s0015-0282(01)01919-7,,,2551667.0,,,Hyperandrogenism by Liquid Chromatography Tandem Mass Spectrometry in PCOS: Focus on Testosterone and Androstenedione,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,37.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
6,1,"1.5.1, 1.5.2",54,53,"Agrawal, N.; Sharma, R. Correlation of anti-müllerian hormone with clinical, hormonal and ultrasonographic parameters in pcos and normo-ovulatory women: An experience of single tertiary care center. Ital J Gynaecol Obstet 2018;30(4):37-43.",primary_citation,,Agrawal,2018,"Agrawal et al., 2018",10.9790/0853-1602085156,,,52258305.0,,,Polycystic Ovary Syndrome Phenotype D Versus Functional Hypothalamic Amenorrhea With Polycystic Ovarian Morphology: A Retrospective Study About a Frequent Differential Diagnosis,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,53.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
8,1,"1.5.1, 1.5.2",69,53,"Farooq S, Baloch S, Awan S, Fakharunissa. Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients with Different Subgroups. Pak J Med Health Sci 2022;16(5):612-615. No doi",primary_citation,,Farooq S,2022,"Farooq S et al., 2022",10.53350/pjmhs22165612 ,,,,,10.53350/pjmhs22165612,Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies,,,,,,,,,,,,,,10.53350/pjmhs22165612,,,,,,,,,,0,,,,,,,,,,,,,,,68.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
9,1,"1.5.1, 1.5.2",71,53,"Gabr H, Marei ES, The Relation between Anti-Mullerian Hormone with Antral Follicle Count and Ovarian Volume in Polycystic Ovary Syndrome. Arab Journal of Nuclear Sciences and Applications 2019;52(2):84-93. ",primary_citation,,Gabr H,2019,"Gabr H et al., 2019",10.21608/ajnsa.2019.3711.1087,,,,,10.21608/ajnsa.2019.3711.1087,Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome,,,,,,,,,,,,,,10.21608/ajnsa.2019.3711.1087,,,,,,,,,,0,,,,,,,,,,,,,,,70.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
10,1,"1.5.1, 1.5.2",78,53,"Kumari A, Tiwari HC, Srivastav R. Comparative Evaluation of Diagnostic Efficacy of Serum Anti-Müllerian Hormone and Ultrasound in Polycystic Ovarian Syndrome. J South Asian Feder Obs Gynae 2018; 10 (2):98-103",primary_citation,,Kumari A,2018,"Kumari A et al., 2018",10.5005/jp-journals-10006-1569,,,,,10.5005/jp-journals-10006-1569,Are There Any Sensitive and Specific Sex Steroid Markers for Polycystic Ovary Syndrome?,,,,,,,,,,,,,,10.5005/jp-journals-10006-1569,,,,,,,,,,0,,,,,,,,,,,,,,,77.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
11,1,"1.5.1, 1.5.2",85,53,"Okcu NT, Nazik H, Akduman AT, Uncu G. The relation between the serum anti-Mullerian hormone levels and follicle count in polycystic ovary syndrome. The European Research Journal. P -2149-3189;4;N1 doi: 10.18621/eurj.332118",primary_citation,,Okcu NT,,"Okcu NT et al., ",10.18621/eurj.332118,,,,,10.18621/eurj.332118,The combination of ovarian volume and outline has better diagnostic accuracy than prostate-specific antigen (PSA) concentrations in women with polycystic ovarian syndrome (PCOs),,,,,,,,,,,,,,10.18621/eurj.332118,,,,,,,,,,0,,,,,,,,,,,,,,,84.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
12,1,"1.5.1, 1.5.2",94,53,"Sharma P, Chawla R, Ahuja R, et al. Anti-Müllerian Hormone as a Surrogate Marker for Hormonal Dysfunction and Sonographic Pattern in Polycystic Ovarian Syndrome. J South Asian Feder Obst Gynae 2019;11(3):175–180. doi: 10.5005/jp-journals-10006-1674",primary_citation,,Sharma P,2019,"Sharma P et al., 2019",10.5005/jp-journals-10006-1674,,,,,10.5005/jp-journals-10006-1674,Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria,,,,,,,,,,,,,,10.5005/jp-journals-10006-1674,,,,,,,,,,0,,,,,,,,,,,,,,,93.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
13,1,"1.5.1, 1.5.2",96,53,"Singh S, Firdaus A, Choudhary R, Dhama V. Role of antimullerian hormone as a diagnostic tool for polycystic ovary syndrome. Int J Reprod Contracept Obstet Gynecol. 2020;9(9):3730. DOI: 10.18203/2320-1770.ijrcog20203847.",primary_citation,,Singh S,2020,"Singh S et al., 2020",10.18203/2320-1770.ijrcog20203847,,,,,10.18203/2320-1770.ijrcog20203847,Hirsutism and oligomenorrhea are appropriate screening criteria for polycystic ovary syndrome in adolescents,,,,,,,,,,,,,,10.18203/2320-1770.ijrcog20203847,,,,,,,,,,0,,,,,,,,,,,,,,,95.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
14,1,"1.5.1, 1.5.2",101,53,"Tunҫ S, and Ozkan B. Analysis of New Biomarkers for the Diagnosis of Polycystic Ovary Syndrome in Adolescents Ergenlerde Polikistik Over Sendromu Tanisi icin Yeni Biyobelirteclerin Analizi. The Journal of Current Pediatrics, vol. 19, no. 3, Dec. 2021, pp. 311+. Gale OneFile: Health and Medicine.",primary_citation,,Tunҫ S,2021,"Tunҫ S et al., 2021",10.4274/jcp.2021.22599,,,,,10.4274/jcp.2021.22599,Prostate specific antigen (PSA) in diagnosis of polycystic ovarian syndrome – a new insight,,,,,,,,,,,,,,10.4274/jcp.2021.22599,,,,,,,,,,0,,,,,,,,,,,,,,,100.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
17,1,1.6,123,47,"Vidya Bharathi R, Swetha S, Neerajaa J, et al. An epidemiological survey: Effect of predisposing factors for PCOS in Indian urban and rural population. Middle East Fertility Society Journal. 2017;22(4):313-316. doi: 10.1016/j.mefs.2017.05.007",primary_citation,,Vidya Bharathi R,2017,"Vidya Bharathi R et al., 2017",10.1016/j.mefs.2017.05.007,,,,,10.1016/j.mefs.2017.05.007,The clinical significance and primary determinants of hirsutism in patients with polycystic ovary syndrome,,,,,,,,,,,,,,10.1016/j.mefs.2017.05.007,,,,,,,,,,0,,,,,,,,,,,,,,,122.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
21,1,1.6,143,47,"Dashti S, Latiffah Abdul L, Habibah Abdul H, et al. Prevalence of Polycystic Ovary Syndrome among Malaysian Female University Staff. Journal of Midwifery & Reproductive Health. 2019;7(1):1560-1568. doi: 10.22038/jmrh.2018.30370.1329",primary_citation,,Dashti S,2019,"Dashti S et al., 2019",10.22038/jmrh.2018.30370.1329,,,,,10.22038/jmrh.2018.30370.1329,Correlation of clinical and biochemical hyperandrogenism in <scp>Thai</scp> women with polycystic ovary syndrome,,,,,,,,,,,,,,10.22038/jmrh.2018.30370.1329,,,,,,,,,,0,,,,,,,,,,,,,,,142.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
22,1,1.9.1,182,18,"Begum, N., Arayousuf, N., Farooq, M. S., Chowdhury, M. A. K. & Ferdous, M. Association of Impaired Glucose Tolerance and Insulin Resistance in Women with Polycystic Ovary Syndrome. Bangladesh Journal of Obstetrics and Gynecology 34(2), 93-98, doi:https://dx.doi.org/10.3329/BJOG.V34I2.58273 (2019).",primary_citation,,Begum,2019,"Begum et al., 2019",10.3329/BJOG.V34I2.58273,,,,,10.3329/bjog.v34i2.58273,The predictive value of total testosterone alone for clinical hyperandrogenism in polycystic ovary syndrome,,,,,,,,,,,,,,10.3329/bjog.v34i2.58273,,,,,,,,,,0,,,,,,,,,,,,,,,181.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
23,1,1.9.1,186,18,"Fuad, Z. F. & Alobaidy, E. J. Association of hba1c levels with body mass index in a patient diagnosed with polycystic ovary syndrome. Indian Journal of Public Health Research and Development 9(7), 298-303, doi:https://dx.doi.org/10.5958/0976-5506.2018.00659.9 (2018).",primary_citation,,Fuad,2018,"Fuad et al., 2018",10.5958/0976-5506.2018.00659.9,,,,,10.5958/0976-5506.2018.00659.9,Improved diagnostic performance for the diagnosis of polycystic ovary syndrome using age-stratified criteria,,,,,,,,,,,,,,10.5958/0976-5506.2018.00659.9,,,,,,,,,,0,,,,,,,,,,,,,,,185.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
24,1,1.9.2,235,6,"Altemimi MT, Musa AK, Mansour AA. The Performance of Glycated Hemoglobin vs. Oral Glucose Tolerance Test in the Diagnosis of Glycemic Disorders among Women with Polycystic Ovary Syndrome in Southern Iraq. The Indonesian Biomedical Journal. 2021 Jun 14;13(2):178-85.",primary_citation,,Altemimi MT,2021,"Altemimi MT et al., 2021",10.1210/jendso/bvab048.891,,,,,10.1210/jendso/bvab048.891,Criteria for Polycystic Ovarian Morphology in Polycystic Ovary Syndrome as a Function of Age,,,,,,,,,,,,,,10.1210/jendso/bvab048.891,,,,,,,,,,0,,,,,,,,,,,,,,,234.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
25,1,1.11,266,23,"Uehara, T., Mitsuhashi, A., & Shozu, M. (2020). The impact of pre-existing polycystic ovary syndrome on endometrial cancer recurrence. European Journal Of Gynaecological Oncology, 41(5), 668. doi: 10.31083/j.ejgo.2020.05.5038",primary_citation,,Uehara,2020,"Uehara et al., 2020",10.31083/j.ejgo.2020.05.5038,,,,,10.31083/j.ejgo.2020.05.5038,The combination of ovarian volume and outline has better diagnostic accuracy than prostate-specific antigen (PSA) concentrations in women with polycystic ovarian syndrome (PCOs),,,,,,,,,,,,,,10.31083/j.ejgo.2020.05.5038,,,,,,,,,,0,,,,,,,,,,,,,,,265.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
29,1,1.12,297,60,"Trottier, A., Battista, M. C., Carpentier, A., Simoneau-Roy, J., Geller, D., & Baillargeon, J. P. (2011). Early metabolic and endocrine perturbations in pre- or peripubertal girls with a first degree relative with polycystic ovary syndrome. Fertility and sterility, 96(3), S129-S129. doi:10.1016/j.fertnstert.2011.07.502",samestudy_296,,Trottier,2011,"Trottier et al., 2011",10.1016/j.fertnstert.2011.07.502,,,,,10.1016/j.fertnstert.2011.07.502,"Follicle number, not assessments of the ovarian stroma, represents the best ultrasonographic marker of polycystic ovary syndrome",,,,,,,,,,,,,,10.1016/j.fertnstert.2011.07.502,,,,,,,,,,0,,,,,,,,,,,,,,,296.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
30,1,1.12,298,60,"Trottier, A., Battista, M. C., Simoneau-Roy, J., Carpentier, A., Geller, D. H., & Baillargeon, J. P. (2011). Early metabolic and endocrine perturbations in first-degree relative adolescent girls of polycystic ovary syndrome women. Endocrine Reviews, 32(3 Meeting Abstracts). ",samestudy_296,,Trottier,2011,"Trottier et al., 2011",10.1016/J.FERTNSTERT.2011.07.502,,W4253108685,,,10.1016/j.fertnstert.2011.07.502,Contribution of real-time elastography in diagnosis of polycystic ovary syndrome,,,,,,,,,,,,,,10.1016/j.fertnstert.2011.07.502,,,,,,,,,,0,,,,,,,,,,,,,,,297.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
31,1,1.12,318,60,"Sir-Petermann, T.; Angel, B.; Maliqueo, M.; Perez-Bravo, F. Glucose tolerance, insulin secretion and insulin resistance in parents of women with polycystic ovary sindrome. Diabetologia 2001;44:A86-A86.",samestudy_313,,Sir-Petermann,2001,"Sir-Petermann et al., 2001",10.1007/BF03180172,,,,,10.1007/bf03180172,Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles,,,,,,,,,,,,,,10.1007/bf03180172,,,,,,,,,,0,,,,,,,,,,,,,,,317.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
34,2,2.1.1 / 2.1.2,339,36,"Jose, S. A.; Ravi, R.; Murthy, M. K. Quality of life in women with polycystic ovarian syndrome: Requisite of clinical pharmacist intervention. Asian Journal of Pharmaceutical and Clinical Research. Conference: 3rd International Conference on Academic and Industrial Innovations: Transitions in Pharmaceutical, Medical and Biosciences, INNOPHARM 2018;11(11): 2018",primary_citation,,Jose,2018,"Jose et al., 2018",10.22159/ajpcr.2019.v12i11.34426,,,,,10.22159/ajpcr.2019.v12i11.34426,Is shear wave elastography relevant in the diagnosis of polycystic ovarian syndrome?,,,,,,,,,,,,,,10.22159/ajpcr.2019.v12i11.34426,,,,,,,,,,0,,,,,,,,,,,,,,,338.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
35,2,2.2,374,80,"Erson Aksu, Elmas Beyazyüz, Yakup Albayrak, Nihan Potas, Ferit Durankuş, Gamze Uvaçin & Murat Beyazyüz (2019) Altered cooperativeness in patients with polycystic ovary syndrome, Psychiatry and Clinical Psychopharmacology, 29:4, 880-886, DOI: 10.1080/24750573.2019.1691357",primary_citation,,Erson Aksu,2019,"Erson Aksu et al., 2019",10.1080/24750573.2019.1691357,,,,,10.1080/24750573.2019.1691357,Impact of right–left differences in ovarian morphology on the ultrasound diagnosis of polycystic ovary syndrome,,,,,,,,,,,,,,10.1080/24750573.2019.1691357,,,,,,,,,,0,,,,,,,,,,,,,,,373.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
36,2,2.2,376,80,"Altinkaya, O., Nergiz, S., Kucuk, M., & Yuksel, H. (2014). Depression and anxiety in relation with hormonal and metabolic profile in women with polycystic ovarian syndrome. Turkiye Klinikleri J Gynecol Obst, 24(3), 159-65.",primary_citation,,Altinkaya,2014,"Altinkaya et al., 2014",,,W1524022481,59115787.0,Beta-cell dysfunction and hyperandrogenemia in PCOS early pubertal female relatives,,Beta-cell dysfunction and hyperandrogenemia in PCOS early pubertal female relatives,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,375.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
37,2,2.2,392,80,"Caltekin, M., Hamamci, M., Onat, T., Kirmizi, D., Baser, E., & Yalvac, E. (2021). Evaluation of Sleep Quality, Restless Legs Syndrome, Anxiety and Depression in Polycystic Ovary Syndrome. Journal Of Turkish Sleep Medicine, 3, 243-249.",primary_citation,,Caltekin,2021,"Caltekin et al., 2021",10.4274/jtsm.galenos.2021.85057,,,,,10.4274/jtsm.galenos.2021.85057,2D and 3D Trans-vaginal Sonography to Determine Cut-offs for Ovarian Volume and Follicle Number per Ovary for Diagnosis of Polycystic Ovary Syndrome in Indian Women,,,,,,,,,,,,,,10.4274/jtsm.galenos.2021.85057,,,,,,,,,,0,,,,,,,,,,,,,,,391.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
38,2,2.2,408,80,"HARMANCI, H., HERGÜNER, S., & TOY, H. (2013). Polikistik Over Sendromu olan Kadınlarda Psikiyatrik Belirtiler / Psychiatric Symptoms in Women with Polycystic Ovary Syndrome. Dusunen Adam: The Journal Of Psychiatry And Neurological Sciences, 26, 157-163. doi: 10.5350/dajpn2013260205",primary_citation,,HARMANCI,2013,"HARMANCI et al., 2013",10.5350/dajpn2013260205,,,,,10.5350/dajpn2013260205,The Relevant Hormonal Levels and Diagnostic Features of Polycystic Ovary Syndrome in Adolescents,,,,,,,,,,,,,,10.5350/dajpn2013260205,,,,,,,,,,0,,,,,,,,,,,,,,,407.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
39,2,2.2,429,80,"Mukundan, A., & Jayakumari, S. (2019). RISK OF DEVELOPING DEPRESSION AND ITS IMPACT ON QUALITY OF LIFE IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME - A SOUTH INDIAN SCENARIO. International Journal Of Pharmaceutical Sciences And Research, 10(6), 2956-2961.",primary_citation,,Mukundan,2019,"Mukundan et al., 2019",10.13040/IJPSR.0975-8232.10(6).2956-61,,,212468337.0,,,Polycystic ovary morphology: age-based ultrasound criteria,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,428.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
41,2,2.2,441,80,"Soyupek, F., Yildiz, S., Akkus, S., Guney, M., Mungan, M., & Eris, S. (2010). The Frequency of Fibromyalgia Syndrome in Patients with Polycystic Ovary Syndrome. Journal Of Musculoskeletal Pain, 18(2), 120-126. doi: 10.3109/10582452.2010.483968",primary_citation,,Soyupek,2010,"Soyupek et al., 2010",10.3109/10582452.2010.483968,,,,,10.3109/10582452.2010.483968,Relationship of ovarian volume with mean platelet volume and lipid profile in patients with polycystic ovary syndrome,,,,,,,,,,,,,,10.3109/10582452.2010.483968,,,,,,,,,,0,,,,,,,,,,,,,,,440.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
42,2,2.3,454,29,"Elkhiat, Y., Zedan, A., Mostafa, M. and Elhalwagi, A., (2015). Sexual desire in a sample of married Egyptian women with polycystic ovarian syndrome. Human Andrology. 2015; 5(3):49-57. DOI:10.1097/01.XHA.0000470182.71509.1b",primary_citation,prior search,Elkhiat,2015,"Elkhiat et al., 2015",10.1097/01.XHA.0000470182.71509.1b,,,,,10.1097/01.xha.0000470182.71509.1b,Do threshold values of ovarian volume and follicle number for diagnosing polycystic ovarian syndrome in Turkish women differ from western countries?,,,,,,,,,,,,,,10.1097/01.xha.0000470182.71509.1b,,,,,,,,,,0,,,,,,,,,,,,,,,453.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
43,2,2.3,458,29,"Gateva, A. and Kamenov, Z., (2012). Sexual Function in Patients with PCOS and/or Obesity before and after Metformin Treatment. Advances in Sexual Medicine. 2012.  DOI: 10.4236/asm.2012.22005.",primary_citation,prior search,Gateva,2012,"Gateva et al., 2012",10.4236/asm.2012.22005,,,,,10.4236/asm.2012.22005,A Cross-Sectional Study on Potential Ovarian Volume and Related Factors in Women with Polycystic Ovary Syndrome from Infertile Couples,,,,,,,,,,,,,,10.4236/asm.2012.22005,,,,,,,,,,0,,,,,,,,,,,,,,,457.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
44,2,2.3,476,29,"Mantzou, D, Stamou, MI, Armeni, AK, Roupas, ND, Assimakopoulos, K, Adonakis, G, Georgopoulos, NA & Markantes, GK. (2021). Impaired sexual function in young women with PCOS: the detrimental effect of anovulation. J Sexual Medicine, 2021;18:1872-1879. doi.org/10.1016/j.jsxm.2021.09.004",primary_citation,,Mantzou,2021,"Mantzou et al., 2021",10.1016/j.jsxm.2021.09.004,,,,,pmid:37057487,Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis,,,,,,,,,,,,,,10.1016/j.jsxm.2021.09.004,pmid:37057487,,,,,,,,,0,,,,,,,,,,,,,,,475.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
45,2,2.3,478,29,"Thagavi, SA, Aramesh, S, Azizi-Kutenaee, M, Allan, H, Safarzadeh, T, Taheri, M, Salari, S, Khashavi & Bazarganipour, F. (2021) The influence of infertility on sexual and marital satisfaction in Iranian women with polycystic ovary syndrome: a case-control study. Middel East Fertilty Society Journal. 2021;26(2). doi.org/10.1186/s43043-020-00047-y",primary_citation,,Thagavi,2021,"Thagavi et al., 2021",10.1186/s43043-020-00047-y,,,,,10.1186/s43043-020-00047-y,Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume,,,,,,,,,,,,,,10.1186/s43043-020-00047-y,,,,,,,,,,0,,,,,,,,,,,,,,,477.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
46,2,2.5,490,14,"Batcheller, A., Ressler, I., Sroga, J., Martinez, A., Thomas, M., Di Paola, K. (2013). Binge eating disorder in the infertile polycystic ovary syndrome patient. Fertility and Sterility, 2013.",primary_citation,Prior search,Batcheller,2013,"Batcheller et al., 2013",10.1016/J.FERTNSTERT.2013.07.631,,,,,10.1016/j.fertnstert.2013.07.631,Comparison of stromal thickness and doppler findings in polycystic ovary syndrome and healthy women with ultrasonographic evidence of polycystic ovaries? A cross-sectional study,,,,,,,,,,,,,,10.1016/j.fertnstert.2013.07.631,,,,,,,,,,0,,,,,,,,,,,,,,,489.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
47,2,2.5,493,14,"Lee, I., Cooney, L., Saini, S., Smith, M., Allison, K. Dokras, A. (2016). Increased risk of eating disorders in women with polycystic ovary syndrome. Fertility and Sterility, 2016.",primary_citation,Prior search,Lee,2016,"Lee et al., 2016",10.1016/J.FERTNSTERT.2016.07.750,,,,,10.1016/j.fertnstert.2016.07.750,Ovarian volume and gluco‐insulinaemic markers in the diagnosis of <scp>PCOS</scp> during adolescence,,,,,,,,,,,,,,10.1016/j.fertnstert.2016.07.750,,,,,,,,,,0,,,,,,,,,,,,,,,492.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
48,2,2.5,497,14,"Maher, M., Sanders, A.(2018). Eating indicators in women with polycystic ovary syndrome and weight-matched controls. FASEB Journal, 2018.",primary_citation,,Maher,2018,"Maher et al., 2018",10.1096/fasebj.31.1_supplement.lb374,,,,,10.1096/fasebj.31.1_supplement.lb374,Hirsutism and oligomenorrhea are appropriate screening criteria for polycystic ovary syndrome in adolescents,,,,,,,,,,,,,,10.1096/fasebj.31.1_supplement.lb374,,,,,,,,,,0,,,,,,,,,,,,,,,496.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
49,2,2.5,498,14,"Lidaka, L., Lazdane, G., Kivite-Urtane, A., Gailite, L., Dzivite-Krisane, I., Stokenberga, I. (2019). Health-related quality of life and binge eating among adolescent girls with PCOS. Clinical and Experimental Obstetrics and Gynecology, 2019.",primary_citation,,Lidaka,2019,"Lidaka et al., 2019",10.31083/j.ceog4903057,,,,,10.31083/j.ceog4903057,Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women,,,,,,,,,,,,,,10.31083/j.ceog4903057,,,,,,,,,,0,,,,,,,,,,,,,,,497.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
51,2,2.6.1,510,41,"Dutta, D., Bhattacharya, S., Khandelwal, D., Aggarwal, S., Singla, R., Surana, V., & Dhingra, A. (2020). Clinical Practice Patterns of Polycystic Ovary Syndrome Among Doctors of Different Specialtiesâ€”An Indian Perspective. US Endocrinology, 16(2), 74-79.",primary_citation,,Dutta,2020,"Dutta et al., 2020",10.17925/USE.2020.16.2.74,,,,,10.17925/use.2020.16.2.74,Serum Anti-Müllerian Hormone in the Diagnosis of Polycystic Ovary Syndrome in Association with Clinical Symptoms,,,,,,,,,,,,,,10.17925/use.2020.16.2.74,,,,,,,,,,0,,,,,,,,,,,,,,,509.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
52,2,2.6.1,516,41,"Salman AD,. Nurses--Midwifes Knowledge Concerning Polycystic Ovary Syndrome in Baghdad Hospitals. Indian Journal of Forensic Medicine & Toxicology. 2020 Oct 1;14(4).",primary_citation,,Salman AD,2020,"Salman AD et al., 2020",10.37506/IJFMT.V14I4.12337,,,,,10.37506/ijfmt.v14i4.12337,,,,,,,,,,,,,,,10.37506/ijfmt.v14i4.12337,,,,,,,,,,0,,,,,,,,,,,,,,,515.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
53,2,2.6.4,553,28,"Crete J, Adamshick P. Managing polycystic ovary syndrome: what our patients are telling us. Journal of Holistic Nursing. 2011 Dec;29(4):256-66.",primary_citation,,Crete J,2011,"Crete J et al., 2011",10.1177/0898010111429092,,,,,10.1177/0898010111429092,Assessment of Anti-Mullerian Hormone and Anti Ovarian Antibody in the Sera of Patients with Polycystic Ovarian Syndrome in AL-Najaf Al-Ashraf Province,,,,,,,,,,,,,,10.1177/0898010111429092,,,,,,,,,,0,,,,,,,,,,,,,,,552.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
54,2,2.6.4,567,28,"Sharma S, Mishra AJ. Tabooed disease in alienated bodies: A study of women suffering from Polycystic Ovary Syndrome (PCOS). Clinical Epidemiology and Global Health. 2018 Sep 1;6(3):130-6.",primary_citation,,Sharma S,2018,"Sharma S et al., 2018",10.1016/J.CEGH.2017.09.001,,,,,10.1016/j.cegh.2017.09.001,Can we use serum Anti-Mullerian hormone to differentiate the diagnosis between polycystic ovary syndrome patients and healthy women with polycystic ovarian morphology and regular menstrual cycles,,,,,,,,,,,,,,10.1016/j.cegh.2017.09.001,,,,,,,,,,0,,,,,,,,,,,,,,,566.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
57,3,3.3,606,12,"Hosseini Marnani E., Ghadiri-Anari A., Ramezani-Jolfaie N., Mohammadi M., Abdollahi, A., Namayandeh S. M., et al. Effect of fennel supplementation along with high-protein, low-carbohydrate weight-loss diet on insulin resistance and percentage of fat and muscle mass in overweight/obese women with polycystic ovary syndrome. Journal of Functional Foods 2020 Vol. 67 Pages 103848. https://doi.org/10.1016/j.jff.2020.103848",primary_citation,,Hosseini Marnani E.,2020,"Hosseini Marnani E. et al., 2020",10.1016/j.jff.2020.103848,,,,,10.1016/j.jff.2020.103848,Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study,,,,,,,,,,,,,,10.1016/j.jff.2020.103848,,,,,,,,,,0,,,,,,,,,,,,,,,605.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
58,3,3.3,614,12,"Panico A, Lupoli GA, Cioffi I, Zacchia G, Caldara A, Lupoli G, Contaldo F, Pasanisi F. Effects of an isocaloric low-glycemic-load diet in polycystic ovary syndrome. Nutr Ther Metab. 2014;32:85–92.",primary_citation,prior search,Panico A,2014,"Panico A et al., 2014",10.5301/NTM.2014.12407,,,,,10.5301/ntm.2014.12407,Anti-Müllerian hormone as a diagnostic tool for PCOS under different diagnostic criteria in an unselected population,,,,,,,,,,,,,,10.5301/ntm.2014.12407,,,,,,,,,,0,,,,,,,,,,,,,,,613.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
60,3,3.5,645,70,"Gopalan U , Ghose S , Karnaboopathy R , Comparison of dietary pattern and BMI in South Indian women with PCOS and controls. Indian J Obstet Gynecol Res 2021;8(1):57-60",primary_citation,,Gopalan U ,2021,"Gopalan U  et al., 2021",10.18231/J.IJOGR.2021.011,,,,,10.18231/j.ijogr.2021.011,The diagnosis of PCOS in young infertile women according to different diagnostic criteria: the role of serum anti-Müllerian hormone,,,,,,,,,,,,,,10.18231/j.ijogr.2021.011,,,,,,,,,,0,,,,,,,,,,,,,,,644.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
62,3,3.6,696,7,"Chopra, S., Zehrung, R., Shanmugam, T. A., & Choe, E. K. (2021, May). Living with uncertainty and stigma: self-experimentation and support-seeking around polycystic ovary syndrome. In Proceedings of the 2021 CHI Conference on Human Factors in Computing Systems (pp. 1-18). https://doi.org/10.1145/3411764. 3445706",primary_citation,,Chopra,2021,"Chopra et al., 2021",10.1145/3411764,,,,,10.1145/3411764,"Serum Copeptin, Pentraxin 3, Anti-Mullerian Hormone Levels With Echocardiography and Carotid Artery Intima-Media Thickness in Adolescents With Polycystic Ovary Syndrome",,,,,,,,,,,,,,10.1145/3411764,,,,,,,,,,0,,,,,,,,,,,,,,,695.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
64,4,4.2 / 4.3,713,85,"Cetinkalp S, Karadeniz M, Erdogan M, Ozgen G, Saygl F, Ylmaz C. The effects of rosiglitazone, metformin, and estradiol-cyproterone acetate on lean patients with polycystic ovary syndrome. The Endocrinologist (Baltimore, Md). 2009;19(3):94-7.",primary_citation,,Cetinkalp S,2009,"Cetinkalp S et al., 2009",10.1097/TEN.0B013E3181A58772,,,,,10.1097/ten.0b013e3181a58772,Age-specific reference values improve the diagnostic performance of AMH in polycystic ovary syndrome,,,,,,,,,,,,,,10.1097/ten.0b013e3181a58772,,,,,,,,,,0,,,,,,,,,,,,,,,712.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
65,4,4.2 / 4.3,743,85,"Kebapcilar L, Yuksel A, Bozkaya G, Taner CE, Kebapcilar AG, Bilgir O, et al. Effects of an EE/CA compared with EE/CA-metformin on serum ADMA levels in women with polycystic ovary syndrome. Central European journal of medicine. 2009;4(4):423-7.",primary_citation,,Kebapcilar L,2009,"Kebapcilar L et al., 2009",10.2478/s11536-009-0074-x,,,,,10.2478/s11536-009-0074-x,Correlation between anti-Mullerian hormone levels and antral follicle counts in polycystic ovary and metabolic syndromes,,,,,,,,,,,,,,10.2478/s11536-009-0074-x,,,,,,,,,,0,,,,,,,,,,,,,,,742.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
66,4,4.2 / 4.3,758,85,"Meyer C, McGrath BP, Teede HJ. Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome. Diabetes care. 2007;30(3):471-8.",primary_citation,,Meyer C,2007,"Meyer C et al., 2007",10.2337/DC06-0618,,,,,10.2337/dc06-0618,Relation between Anti-Müllerian Hormone with Antral Follicle Count and Ovarian Volume in Polycystic Ovary Syndrome,,,,,,,,,,,,,,10.2337/dc06-0618,,,,,,,,,,0,,,,,,,,,,,,,,,757.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
67,4,4.2 / 4.3,761,85,"Moran LJ, Meyer C, Hutchison SK, Zoungas S, Teede HJ. Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention. J Endocrinol Invest. 2010;33(4):258-65.",primary_citation,,Moran LJ,2010,"Moran LJ et al., 2010",10.1007/BF03345790,,,,,10.1007/bf03345790,Simplified 4‐item criteria for polycystic ovary syndrome: A bridge too far?,,,,,,,,,,,,,,10.1007/bf03345790,,,,,,,,,,0,,,,,,,,,,,,,,,760.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
68,4,4.2 / 4.3,779,85,"Taheripanah R, Sepahvandi M, Entezari A, Amiri Z, Samani EN. Evaluation of serum PSA after cyproterone compound treatment compared with oral contraceptive pill in hirsute polycystic ovary syndrome patients. Middle East Fertility Society journal. 2010;15(3):159-62.",primary_citation,,Taheripanah R,2010,"Taheripanah R et al., 2010",10.1016/J.MEFS.2010.06.007,,,,,10.1016/j.mefs.2010.06.007,Anti-Müllerian hormone reflects the severity of polycystic ovary syndrome,,,,,,,,,,,,,,10.1016/j.mefs.2010.06.007,,,,,,,,,,0,,,,,,,,,,,,,,,778.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
69,4,4.4,791,111,"Chou, K.H., et al., Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double blind and placebo‐controlled trial. Hormone & Metabolic Research, 2003. 35(2): p. 86‐91. (ROB included in last TR under Patel 2017) ",primary_citation,,Chou,2003,"Chou et al., 2003",10.1055/S-2003-39056,,,,,10.1055/s-2003-39056,Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria,,,,,,,,,,,,,,10.1055/s-2003-39056,,,,,,,,,,0,,,,,,,,,,,,,,,790.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
72,4,4.4,829,111,"El Maghraby HA, Nafee T, Guiziry D, Elnashar A. Randomized controlled trial of the effects of metformin versus combined oral contraceptives in adolescent PCOS women through a 24 months follow up period. Middle East Fertility Society Journal 2015 (ROB included in last TR under Al Khalifa 2016)",primary_citation,,El Maghraby HA,2015,"El Maghraby HA et al., 2015",10.1016/J.MEFS.2014.10.003,,,,,10.1016/j.mefs.2014.10.003,Anti-Müllerian Hormone in Obese Adolescent Girls With Polycystic Ovary Syndrome,,,,,,,,,,,,,,10.1016/j.mefs.2014.10.003,,,,,,,,,,0,,,,,,,,,,,,,,,828.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
73,4,4.4,836,111,"Meyer C, McGrath BP, Teede HJ. Effect of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome. Diabetes Care 2007",primary_citation,,Meyer C,2007,"Meyer C et al., 2007",10.2337/DC06-0618,,,,,10.2337/dc06-0618,Comparative Evaluation of Diagnostic Efficacy of Serum Anti-Müllerian Hormone and Ultrasound in Polycystic Ovarian Syndrome,,,,,,,,,,,,,,10.2337/dc06-0618,,,,,,,,,,0,,,,,,,,,,,,,,,835.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
74,4,4.4,838,111,"Moran LJ, Meyer C, Hutchison SK, Zoungas S, Teede HJ. Novel inflammatory markers in overweight women with or without polycystic ovary syndrome and following pharmacological intervention. Journal of Endocrinological Investigation 2010",primary_citation,,Moran LJ,2010,"Moran LJ et al., 2010",10.1007/BF03345790,,,,,10.1007/bf03345790,Exploration of the role of anti‐Mullerian hormone and LH/FSH ratio in diagnosis of polycystic ovary syndrome,,,,,,,,,,,,,,10.1007/bf03345790,,,,,,,,,,0,,,,,,,,,,,,,,,837.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
75,4,4.4,845,111,"Kebapcilar, Levent; Yuksel, Arif; Bozkaya, Giray; Taner, Cuneyt Eftal; Kebapcilar, Ayse Gul; Bilgir, Oktay; Alacacioglu, Ahmet; Sari, Ismail Effects of an EE/CA compared with EE/CA-metformin on serum ADMA levels in women with polycystic ovary syndrome Central European journal of medicine 2009;4(4):423-427. ",primary_citation,,Kebapcilar,2009,"Kebapcilar et al., 2009",10.2478/s11536-009-0074-x,,,,,10.2478/s11536-009-0074-x,Age‐specific reference ranges of serum anti‐müllerian hormone in healthy women and its application in diagnosis of polycystic ovary syndrome: a population study,,,,,,,,,,,,,,10.2478/s11536-009-0074-x,,,,,,,,,,0,,,,,,,,,,,,,,,844.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
76,4,4.4,885,111,"Cetinkalp, S., Karadeniz, M., Erdogan, M., Ozgen, G., Saygl, F. and Ylmaz, C. 2009 The effects of rosiglitazone, metformin, and estradiol‐cyproterone acetate on lean patients with polycystic ovary syndrome. Endocrinologist. 2009 ",primary_citation,,Cetinkalp,2009,"Cetinkalp et al., 2009",10.1097/TEN.0B013E3181A58772,,,,,10.1097/ten.0b013e3181a58772,Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis,,,,,,,,,,,,,,10.1097/ten.0b013e3181a58772,,,,,,,,,,0,,,,,,,,,,,,,,,884.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
77,4,4.4,892,111,"Ahmad J, Shukla N, Khan AR, Ahmed F, Siddiqui MA. Comparisonof metabolic effects of metformin and rosiglitazone in the man-agement of polycystic ovary syndrome (PCOS): A prospective,parallel, randomized, open‐label study.Diabetes  Metab  Syndr:  ClinRes Rev. 2008 ",primary_citation,,Ahmad J,2008,"Ahmad J et al., 2008",10.1016/J.DSX.2007.12.003,,,,,10.1016/j.dsx.2007.12.003,Antimüllerian hormone and polycystic ovary syndrome,,,,,,,,,,,,,,10.1016/j.dsx.2007.12.003,,,,,,,,,,0,,,,,,,,,,,,,,,891.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
78,4,4.5,913,17,"Zheng, S., Zhang, Y., Long, T., Lu, J., Liu, X., Yan, J., . . . Wang, F. (2017). Short term monotherapy with exenatide is superior to metformin in weight loss, improving insulin resistance and inflammation in Chinese overweight/obese PCOS women. Obesity Medicine, 7, 15-20. doi:https://doi.org/10.1016/j.obmed.2017.06.003 (primary citation)",primary_citation,,Zheng,2017,"Zheng et al., 2017",10.1016/j.obmed.2017.06.003,,,,,10.1016/j.obmed.2017.06.003,Establishing an Anti-Müllerian hormone cutoff for diagnosis of polycystic ovarian syndrome in women of reproductive age-bearing Indian ethnicity using the automated Anti-Müllerian hormone assay,,,,,,,,,,,,,,10.1016/j.obmed.2017.06.003,,,,,,,,,,0,,,,,,,,,,,,,,,912.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
79,4,4.6,934,26,"Meyer C, McGrath BP, Teede HJ. Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome. Diabetes Care 2007;30(3):471-8. doi: 10.2337/dc06-0618.",primary_citation,,Meyer C,2007,"Meyer C et al., 2007",10.2337/dc06-0618,,,,,10.2337/dc06-0618,Relationship between serum anti-Mullerian hormone and clinical parameters in polycystic ovary syndrome,,,,,,,,,,,,,,10.2337/dc06-0618,,,,,,,,,,0,,,,,,,,,,,,,,,933.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
80,4,4.7,942,29,"Angik, Riju, Shubhada S. Jajoo, C. Hariharan, and Amogh Chimote. 2017. “A Comparative Study of Metabolic and Hormonal Effects of Myoinositol vs. Metformin in Women with Polycystic Ovary Syndrome: A Randomised Controlled Trial.” International Journal of Reproduction, Contraception, Obstetrics and Gynecology; Vol 4, No 1 (2015): January-February 2015. https://www.ijrcog.org/index.php/ijrcog/article/view/1838/1588.
",primary_citation,,Angik,2017,"Angik et al., 2017",10.5455/2320-1770.IJRCOG20150234,,,,,10.5455/2320-1770.ijrcog20150234,The relation between serum anti-Mullerian hormone levels and follicle count in polycystic ovary syndrome,,,,,,,,,,,,,,10.5455/2320-1770.ijrcog20150234,,,,,,,,,,0,,,,,,,,,,,,,,,941.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
81,4,4.7,946,29,"Chirania, Kishan, Sujata Misra, and Sandhya Behera. 2017. “A Randomised Clinical Trial Comparing Myoinositol and Metformin in PCOS.” International Journal of Reproduction, Contraception, Obstetrics and Gynecology; Vol 6, No 5 (2017): May 2017DO  - 10.18203/2320-1770.Ijrcog20171563. https://www.ijrcog.org/index.php/ijrcog/article/view/2671.
",primary_citation,,Chirania,2017,"Chirania et al., 2017",10.18203/2320-1770.Ijrcog20171563,,,,,10.18203/2320-1770.ijrcog20171563,Anti Mullerian hormone as a diagnostic tool for polycystic ovary syndrome in women of reproductive age with morbid obesity,,,,,,,,,,,,,,10.18203/2320-1770.ijrcog20171563,,,,,,,,,,0,,,,,,,,,,,,,,,945.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
83,4,4.7,954,29,"Maria Concetta Musacchio, Vincenzo De Leo. 2013. “A Combined Treatment with Myo-Inositol and Monacolin K Improve the Androgen and Lipid Profiles of Insulin-Resistant PCOS Patients.” J Metabolic Synd 02 (02). https://doi.org/10.4172/2167-0943.1000127.",primary_citation,,Maria Concetta Musacchio,2013,"Maria Concetta Musacchio et al., 2013",10.4172/2167-0943.1000127,,,,,10.4172/2167-0943.1000127,Anogenital distance and anti-Müllerian hormone combined improves the diagnosis of polycystic ovary syndrome,,,,,,,,,,,,,,10.4172/2167-0943.1000127,,,,,,,,,,0,,,,,,,,,,,,,,,953.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
85,4,4.7,957,29,"Nehra, J., J. Kaushal, S.R. Singhal, and V.S. Ghalaut., 2017b. “Comparision of Myo-Inositol versus Metformin on Anthropometric Parameters in Polycystic Ovarian Syndrome in Women.” International Journal of Pharmacy and Pharmaceutical Sciences 9 (4): 144–48. https://doi.org/10.22159/ijpps.2017v9i4.16359.",samestudy_956,,Nehra,2017b,"Nehra et al., 2017b",10.22159/ijpps.2017v9i4.16359,,,,,10.22159/ijpps.2017v9i4.16359,Age-specific cut-off levels of anti-Müllerian hormone can be used as diagnostic markers for polycystic ovary syndrome,,,,,,,,,,,,,,10.22159/ijpps.2017v9i4.16359,,,,,,,,,,0,,,,,,,,,,,,,,,956.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
86,4,4.7,958,29,"Nestler, J.E., D.J. Jakubowicz, P. Reamer, R.D. Gunn, and G. Allan. 1999. “Ovulatory and Metabolic Effects of D-Chiro-Inositol in the Polycystic Ovary Syndrome.” New England Journal of Medicine 340 (17): 1314–20. https://doi.org/10.1056/NEJM199904293401703.
",primary_citation,,Nestler,1999,"Nestler et al., 1999",10.1056/NEJM199904293401703,,,,,10.1056/nejm199904293401703,Anti‐Müllerian hormone measurement for the diagnosis of polycystic ovary syndrome,,,,,,,,,,,,,,10.1056/nejm199904293401703,,,,,,,,,,0,,,,,,,,,,,,,,,957.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
87,4,4.10.,1012,109,"Hu, S.; Leonard, A.; Seifalian, A.; et al. (2007): Vascular dysfunction during pregnancy in women with polycystic ovary syndrome. Human Reproduction 22, 6, 1532-1539. https://dx.doi.org/10.1093/humrep/dem028.",primary_citation,prior search,Hu,2007,"Hu et al., 2007",10.1093/humrep/dem028,,,,,10.1093/humrep/dem028,"Do the Anti-Müllerian Hormone Levels of Adolescents with Polycystic Ovary Syndrome, Those Who Are at Risk for Developing Polycystic Ovary Syndrome, and Those Who Exhibit Isolated Oligomenorrhea Differ from Those of Adolescents with Normal Menstrual Cycles?",,,,,,,,,,,,,,10.1093/humrep/dem028,,,,,,,,,,0,,,,,,,,,,,,,,,1011.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
88,4,4.10.,1016,109,"Gupta, A.; Raina, K.; Kalkkar, T.; et al. (2009): Pregnancy outcome in women with the polycystic ovarian syndrome. JK Science 11, 2, 82-84, http://www.jkscience.org/archive/vol112/8%20Original%20Article-Pregnancy%20Outcome%20-.pdf",primary_citation,prior search,Gupta,2009,"Gupta et al., 2009",,,W2408925727,59140811.0,Pregnancy outcome in women with the polycystic ovarian syndrome,,Pregnancy outcome in women with the polycystic ovarian syndrome,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,1015.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
89,4,4.10.,1025,109,"Nouh, A. A.; Shalaby, S. M. (2011): The predictive value of uterine blood flow in detecting the risk of adverse pregnancy outcome in patients with polycystic ovary syndrome. Middle East Fertility Society Journal 16, 4, 284-290. http://dx.doi.org/10.1016/j.mefs.2011.09.001.",primary_citation,prior search,Nouh,2011,"Nouh et al., 2011",10.1016/j.mefs.2011.09.001,,,,,10.1016/j.mefs.2011.09.001,Anti-Müllerian Hormone as a Surrogate Marker for Hormonal Dysfunction and Sonographic Pattern in Polycystic ovarian syndrome,,,,,,,,,,,,,,10.1016/j.mefs.2011.09.001,,,,,,,,,,0,,,,,,,,,,,,,,,1024.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
90,4,4.10.,1033,109,"Elkholi, D. G. E. Y.; Nagy, H. M. (2014): The effects of adipocytokines on the endocrino-metabolic features and obstetric outcome in pregnant obese women with polycystic ovary syndrome. Middle East Fertility Society Journal 19, 4, 293-302. http://dx.doi.org/10.1016/j.mefs.2014.02.001.",primary_citation,prior search,Elkholi,2014,"Elkholi et al., 2014",10.1016/j.mefs.2014.02.001,,,,,10.1016/j.mefs.2014.02.001,Role of anti-mullerian hormone as a diagnostic tool for polycystic ovary syndrome,,,,,,,,,,,,,,10.1016/j.mefs.2014.02.001,,,,,,,,,,0,,,,,,,,,,,,,,,1032.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
91,5,5.1,1103,65,"Abu-Fakher B, Al-Quobaili F, Alhalabi M. Follicular fluid antimullerian hormone (AMH) does not predict IVF outcomes in polycystic ovary syndrome patients. Middle East Fertility Society Journal. 2013;18(2):110-4.",primary_citation,,Abu-Fakher B,2013,"Abu-Fakher B et al., 2013",10.1016/J.MEFS.2012.12.005,,,,,10.1016/j.mefs.2012.12.005,Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Müllerian hormone cutoff value,,,,,,,,,,,,,,10.1016/j.mefs.2012.12.005,,,,,,,,,,0,,,,,,,,,,,,,,,1102.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
93,5,5.1,1110,65,"Bakir VL, Karahan G. Evaluation of obesity and metabolic status in polycystic ovary syndrome in fertile and infertile groups. Zeynep Kamil Tip Bulteni. 2019;50(2):44-8.",primary_citation,,Bakir VL,2019,"Bakir VL et al., 2019",10.16948/ZKTIPB.558143,,,,,10.16948/zktipb.558143,"Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes",,,,,,,,,,,,,,10.16948/zktipb.558143,,,,,,,,,,0,,,,,,,,,,,,,,,1109.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
95,5,5.5,1226,12,"Yadav P, Singh S, Singh R, Jain M, Awasthi S, Raj P. To study the effect on fertility outcome by gonadotropins vs laparoscopic ovarian drilling in clomiphene-resistant cases of polycystic ovarian syndrome. Journal of SAFOG 2017; 9(4): 336‐340.",primary_citation,,Yadav P,2017,"Yadav P et al., 2017",10.5005/JP-JOURNALS-10006-1525,,,,,10.5005/jp-journals-10006-1525,Analysis of New Biomarkers for the Diagnosis of Polycystic Ovary Syndrome in Adolescents,,,,,,,,,,,,,,10.5005/jp-journals-10006-1525,,,,,,,,,,0,,,,,,,,,,,,,,,1225.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
96,5,5.6,1230,6,"Farquhar CM, Williamson K, Gudex G, Johnson NP, Garland J, Sadler L. A randomized controlled trial of laparoscopic ovarian diathermy versus gonadotropin therapy for women with clomiphene citrate-resistant polycystic ovary syndrome. Fertil Steril. 2002 Aug;78(2):404-11. doi: 10.1016/s0015-0282(02)03225-9.",primary_citation,,Farquhar CM,2002,"Farquhar CM et al., 2002",10.1016/s0015-0282(02)03225-9,,,24959997.0,,,A patient-specific model combining antimüllerian hormone and body mass index as a predictor of polycystic ovary syndrome and other oligo-anovulation disorders,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,1229.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
97,5,5.6,1232,6,"Sharma, M., Kriplani, A., & Agarwal, N. (2006). Laparoscopic bipolar versus unipolar ovarian drilling in infertile women with resistant polycystic ovarian syndrome: a pilot study. Journal of gynecologic surgery, 22(3), 105-111.",primary_citation,,Sharma,2006,"Sharma et al., 2006",10.1089/GYN.2006.22.105,,,,,10.1089/gyn.2006.22.105,Hirsutism and oligomenorrhea are appropriate screening criteria for polycystic ovary syndrome in adolescents,,,,,,,,,,,,,,10.1089/gyn.2006.22.105,,,,,,,,,,0,,,,,,,,,,,,,,,1231.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
98,5,5.6,1233,6,"Yadav P, Singh S, Singh R, Jain M, Awasthi S, Raj P. To study the effect on fertility outcome by gonadotropins vs laparoscopic ovarian drilling in clomiphene-resistant cases of polycystic ovarian syndrome. Journal of SAFOG 2017; 9(4): 336‐340.",primary_citation,,Yadav P,2017,"Yadav P et al., 2017",10.5005/JP-JOURNALS-10006-1525,,,,,10.5005/jp-journals-10006-1525,Associations of different molecular forms of antimüllerian hormone and biomarkers of polycystic ovary syndrome and normal women,,,,,,,,,,,,,,10.5005/jp-journals-10006-1525,,,,,,,,,,0,,,,,,,,,,,,,,,1232.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
99,5,5.7.1,1234,7,"Ashrafi, Mahnaz & Moini, Ashraf & Mohammadzadeh, Afsaneh & Ezabadi, Zahra & Zafarani, Fatemeh & Baghestani, Ahmad. (2005). A comparative study of GnRH antagonist and GnRH agonist in PCO patients undergoing IVF/ICSI cycles. Iranian Journal of Reproductive Medicine (ISSN: 1680-6433) Vol 3 Num 1. 3. ",primary_citation,,Ashrafi,2005,"Ashrafi et al., 2005",,,W2162847277,54603939.0,A comparative study of GnRH antagonist and GnRH agonist in PCO patients undergoing IVF/ICSI cycles. Iranian Journal of Reproductive Medicine,,A comparative study of GnRH antagonist and GnRH agonist in PCO patients undergoing IVF/ICSI cycles. Iranian Journal of Reproductive Medicine,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,1233.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2,1,"1.5.1, 1.5.2",66,53,"Deveer M, Deveer R, Basaran O, Turkcu UO, Akbaba E, Cullu N, Turhan N, Kucuk M, Kasap B. Serum Copeptin, Pentraxin 3, Anti-Mullerian Hormone Levels With Echocardiography and Carotid Artery Intima-Media Thickness in Adolescents With Polycystic Ovary Syndrome. J Clin Med Res. 2015 Dec;7(12):989-94. doi: 10.14740/jocmr2375w. Epub 2015 Oct 23. PMID: 26566413; PMCID: PMC4625820.",primary_citation,,Deveer M,2015,"Deveer M et al., 2015",10.14740/jocmr2375w,26566413.0,,,,,"Serum Copeptin, Pentraxin 3, Anti-Mullerian Hormone Levels With Echocardiography and Carotid Artery Intima-Media Thickness in Adolescents With Polycystic Ovary Syndrome",,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,26566413.0,,,,,,,,,
7,1,1.6,150,47,"Park YJ, Shin H, Jeon S, Cho I, Kim YJ. Menstrual Cycle Patterns and the Prevalence of Premenstrual Syndrome and Polycystic Ovary Syndrome in Korean Young Adult Women. Healthcare (Basel). 2021 Jan 7;9(1):56. doi: 10.3390/healthcare9010056. PMID: 33430265; PMCID: PMC7825721.",primary_citation,,Park YJ,2021,"Park YJ et al., 2021",10.3390/healthcare9010056,33430265.0,,,,,Menstrual Cycle Patterns and the Prevalence of Premenstrual Syndrome and Polycystic Ovary Syndrome in Korean Young Adult Women,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,33430265.0,,,,,,,,,
10,2,2.2,378,80,"Annagür BB, Tazegül A, Akbaba N. Body Image, Self-Esteem and Depressive Symptomatology in Women with Polycystic Ovary Syndrome. Noro Psikiyatr Ars. 2014 Jun;51(2):129-132. doi: 10.4274/npa.y6778. Epub 2014 Jun 1. PMID: 28360612; PMCID: PMC5353087.",primary_citation,,Annagür BB,2014,"Annagür BB et al., 2014",10.4274/npa.y6778,28360612.0,,,,,"Polikistik Over Sendromu Olan Kadınlarda Beden Algısı, Benlik Saygısı ve Depresif Belirtiler",,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,28360612.0,,,,,,,,,
11,2,2.2,401,80,"Enjezab B, Eftekhar M, Ghadiri-Anari A. Association between severity of depression and clinico-biochemical markers of polycystic ovary syndrome. Electron Physician. 2017 Nov 25;9(11):5820-5825. doi: 10.19082/5820. PMID: 29403625; PMCID: PMC5783134.",primary_citation,,Enjezab B,2017,"Enjezab B et al., 2017",10.19082/5820,29403625.0,,,,,Association between severity of depression and clinico-biochemical markers of polycystic ovary syndrome,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,29403625.0,,,,,,,,,
12,2,2.2,412,80,"Hussain A, Chandel RK, Ganie MA, Dar MA, Rather YH, Wani ZA, Shiekh JA, Shah MS. Prevalence of psychiatric disorders in patients with a diagnosis of polycystic ovary syndrome in kashmir. Indian J Psychol Med. 2015 Jan-Mar;37(1):66-70. doi: 10.4103/0253-7176.150822. PMID: 25722515; PMCID: PMC4341314.",primary_citation,,Hussain A,2015,"Hussain A et al., 2015",10.4103/0253-7176.150822,25722515.0,,,,,Prevalence of Psychiatric Disorders in Patients with a Diagnosis of Polycystic Ovary Syndrome in Kashmir,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,25722515.0,,,,,,,,,
13,2,2.2,437,80,"Sayyah-Melli M, Alizadeh M, Pourafkary N, Ouladsahebmadarek E, Jafari-Shobeiri M, Abbassi J, Kazemi-Shishvan MA, Sedaghat K. Psychosocial Factors Associated with Polycystic Ovary Syndrome: a Case Control Study. J Caring Sci. 2015 Sep 1;4(3):225-31. doi: 10.15171/jcs.2015.023. PMID: 26464839; PMCID: PMC4591610.",primary_citation,,Sayyah-Melli M,2015,"Sayyah-Melli M et al., 2015",10.15171/jcs.2015.023,26464839.0,,,,,Psychosocial Factors Associated with Polycystic Ovary Syndrome: a Case Control Study,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,26464839.0,,,,,,,,,
14,2,2.2,442,80,"Sulaiman MA, Al-Farsi YM, Al-Khaduri MM, Waly MI, Saleh J, Al-Adawi S. Psychological burden among women with polycystic ovarian syndrome in Oman: a case-control study. Int J Womens Health. 2017 Dec 12;9:897-904. doi: 10.2147/IJWH.S145383. PMID: 29276413; PMCID: PMC5731436.",primary_citation,,Sulaiman MA,2017,"Sulaiman MA et al., 2017",10.2147/ijwh.s145383,29276413.0,,,,,Psychological burden among women with polycystic ovarian syndrome in Oman: a case&amp;ndash;control study,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,29276413.0,,,,,,,,,
18,2,2.5,501,14,"Asdaq, S., Jomah, S., Hasa, R., Al-Baroundi, D., Alharbi, M., Alsubaie, S., Buhamad, M., Alyahya, B., Al-Yamani, MM. (2020). Impact of polycystic ovary syndrome on eating behavior, depression, and health related quality of life: A cross-sectional study in Riyadh. Saudi J Biol Sci, 2020.",primary_citation,,Asdaq,2020,"Asdaq et al., 2020",10.1016/j.sjbs.2020.08.039,,,,,,"Impact of polycystic ovary syndrome on eating behavior, depression and health related quality of life: A cross-sectional study in Riyadh",,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,left_only,,,,,,,,,,,,10.1016/j.sjbs.2020.08.039,,,,,,,,,,,,,,,,33304140.0,,,,,,,,,
19,2,2.6.1,542,41,"Williams S, Sheffield D, Knibb RC. â€˜Everythingâ€™s from the inside out with PCOSâ€™: Exploring womenâ€™s experiences of living with polycystic ovary syndrome and co-morbidities through Skypeâ„¢ interviews. Health psychology open. 2015 Aug 28;2(2):2055102915603051.",primary_citation,,Williams S,2015,"Williams S et al., 2015",10.1177/2055102915603051,,,,,,‘Everything’s from the inside out with PCOS’: Exploring women’s experiences of living with polycystic ovary syndrome and co-morbidities through Skype™ interviews,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,left_only,,,,,,,,,,,,10.1177/2055102915603051,,,,,,,,,,,,,,,,28070371.0,,,,,,,,,
21,2,2.6.4,562,28,"Kitzinger C, Willmott J. ‘The thief of womanhood’: women's experience of polycystic ovarian syndrome. Social science & medicine. 2002 Feb 1;54(3):349-61.",primary_citation,,Kitzinger C,2002,"Kitzinger C et al., 2002",10.1016/s0277-9536(01)00034-x,,,,,,‘The thief of womanhood’: women's experience of polycystic ovarian syndrome,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,left_only,,,,,,,,,,,,10.1016/s0277-9536(01)00034-x,,,,,,,,,,,,,,,,,,,,,,,,,
22,2,2.6.4,573,28,"Williams S, Sheffield D, Knibb RC. ‘Everything’s from the inside out with PCOS’: Exploring women’s experiences of living with polycystic ovary syndrome and co-morbidities through Skype™ interviews. Health psychology open. 2015 Aug 28;2(2):2055102915603051.",primary_citation,,Williams S,2015,"Williams S et al., 2015",10.1177/2055102915603051,,,,,,‘Everything’s from the inside out with PCOS’: Exploring women’s experiences of living with polycystic ovary syndrome and co-morbidities through Skype™ interviews,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,left_only,,,,,,,,,,,,10.1177/2055102915603051,,,,,,,,,,,,,,,,28070371.0,,,,,,,,,
23,3,3.1,598,18,"Turan V, Mutlu EK, Solmaz U, Ekin A, Tosun O, Tosun G, et al. Benefits of short‐term structured exercise in non‐overweight women with polycystic ovary syndrome: a prospective randomised controlled study. Journal of Physical Therapy Science 2015;27(7):2293‐7.",primary_citation,prior search,Turan V,2015,"Turan V et al., 2015",10.1589/jpts.27.2293,,,,,,Benefits of short-term structured exercise in non-overweight women with polycystic ovary syndrome: a prospective randomized controlled study,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,left_only,,,,,,,,,,,,10.1589/jpts.27.2293,,,,,,,,,,,,,,,,26311969.0,,,,,,,,,
25,3,3.5,625,70,"Ahmadi A, Akbarzadeh M, Mohammadi F, Akbari M, Jafari B, Tolide-Ie HR. Anthropometric characteristics and dietary pattern of women with polycystic ovary syndrome. Indian J Endocrinol Metab. 2013 Jul;17(4):672-6. doi: 10.4103/2230-8210.113759. PMID: 23961484; PMCID: PMC3743368.",primary_citation,,Ahmadi A,2013,"Ahmadi A et al., 2013",10.4103/2230-8210.113759,23961484.0,,,,,Anthropometric characteristics and dietary pattern of women with polycystic ovary syndrome,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,23961484.0,,,,,,,,,
26,3,3.5,636,70,"Cutler DA, Pride SM, Cheung AP. Low intakes of dietary fiber and magnesium are associated with insulin resistance and hyperandrogenism in polycystic ovary syndrome: A cohort study. Food Sci Nutr. 2019 Feb 27;7(4):1426-1437. doi: 10.1002/fsn3.977. PMID: 31024716; PMCID: PMC6475723.",primary_citation,,Cutler DA,2019,"Cutler DA et al., 2019",10.1002/fsn3.977,31024716.0,,,,,Low intakes of dietary fiber and magnesium are associated with insulin resistance and hyperandrogenism in polycystic ovary syndrome: A cohort study,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,31024716.0,,,,,,,,,
28,3,3.5,652,70,"Khademi A, Alleyassin A, Aghahosseini M, Tabatabaeefar L, Amini M. The Effect of Exercise in PCOS Women Who Exercise Regularly. Asian J Sports Med. 2010 Mar;1(1):35-40. doi: 10.5812/asjsm.34874. PMID: 22375190; PMCID: PMC3289164.",primary_citation,,Khademi A,2010,"Khademi A et al., 2010",10.5812/asjsm.34874,22375190.0,,,,,The Effect of Exercise in PCOS Women Who Exercise Regularly,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,22375190.0,,,,,,,,,
29,3,3.5,671,70,"Shishehgar F, Ramezani Tehrani F, Mirmiran P, Hajian S, Baghestani AR, Moslehi N. Comparison of Dietary Intake between Polycystic Ovary Syndrome Women and Controls. Glob J Health Sci. 2016 Sep 1;8(9):54801. doi: 10.5539/gjhs.v8n9p302. PMID: 27157182; PMCID: PMC5064084.",primary_citation,,Shishehgar F,2016,"Shishehgar F et al., 2016",10.5539/gjhs.v8n9p302,27157182.0,,,,,Comparison of Dietary Intake between Polycystic Ovary Syndrome Women and Controls,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,27157182.0,,,,,,,,,
30,3,3.5,672,70,"Shishehgar F, Tehrani FR, Mirmiran P, Hajian S, Baghestani AR, Moslehi N. Factors Influencing Physical Activity in Women with Polycystic Ovary Syndrome in Comparison to Eumenorrheic Non Hirsute Women. Glob J Health Sci. 2016 Oct 1;8(10):56382. doi: 10.5539/gjhs.v8n10p127. PMID: 27302456.",primary_citation,,Shishehgar F,2016,"Shishehgar F et al., 2016",10.5539/gjhs.v8n10p127,27302456.0,,,,,Factors Influencing Physical Activity in Women with Polycystic Ovary Syndrome in Comparison to Eumenorrheic Non Hirsute Women,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,27302456.0,,,,,,,,,
32,4,4.2 / 4.3,747,85,"Kumar Y, Kotwal N, Singh Y, Upreti V, Somani S, Hari Kumar KVS. A randomized, controlled trial comparing the metformin, oral contraceptive pills and their combination in patients with polycystic ovarian syndrome. J Family Med Prim Care. 2018;7(3):551-6.",primary_citation,,Kumar Y,2018,"Kumar Y et al., 2018",10.4103/jfmpc.jfmpc_83_17,,,,,,"A randomized, controlled trial comparing the metformin, oral contraceptive pills and their combination in patients with polycystic ovarian syndrome",,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,left_only,,,,,,,,,,,,10.4103/jfmpc.jfmpc_83_17,,,,,,,,,,,,,,,,30112307.0,,,,,,,,,
33,4,4.4,834,111,"Kumar Y, Kotwal N, Singh Y, Upreti V, Somani S, Hari Kumar KV. A randomized, controlled trial comparing the metformin, oral contraceptive pills and their combination in patients with polycystic ovarian syndrome. Journal of Family Medicine and Primary Care 2018 ",primary_citation,,Kumar Y,2018,"Kumar Y et al., 2018",10.4103/jfmpc.jfmpc_83_17,,,,,,"A randomized, controlled trial comparing the metformin, oral contraceptive pills and their combination in patients with polycystic ovarian syndrome",,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,left_only,,,,,,,,,,,,10.4103/jfmpc.jfmpc_83_17,,,,,,,,,,,,,,,,30112307.0,,,,,,,,,
34,4,4.4,878,111,"Diri, H.; Bayram, F.; Simsek, Y.; Caliskan, Z.; Kocer, D. Comparison of Finasteride, Metformin, and Finasteride Plus Metformin in Pcos. Acta Endocrinol (Buchar) Jan-Mar 2017;13(1):84-89",primary_citation,,Diri,2017,"Diri et al., 2017",10.4183/aeb.2017.84,,,,,,"Comparison of Finasteride, Metformin, and Finasteride Plus Metformin in PCOS",,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,left_only,,,,,,,,,,,,10.4183/aeb.2017.84,,,,,,,,,,,,,,,,31149153.0,,,,,,,,,
35,4,4.4,890,111,"Shahebrahimi K, Jalilian N, Bazgir N, Rezaei M. Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome. Indian J Endocrinol Metab. 2016 ",primary_citation,,Shahebrahimi K,2016,"Shahebrahimi K et al., 2016",10.4103/2230-8210.192925,,,,,,Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,left_only,,,,,,,,,,,,10.4103/2230-8210.192925,,,,,,,,,,,,,,,,27867884.0,,,,,,,,,
36,4,4.4,897,111,"Steiner CA, Janez A, Jensterle M, Reisinger K, Forst T, Pfützner A. Impact of treatment with rosiglitazone or metformin on biomarkers for insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome. J Diabetes Sci Technol. 2007",primary_citation,,Steiner CA,2007,"Steiner CA et al., 2007",10.1177/193229680700100212,,,,,,Impact of Treatment with Rosiglitazone or Metformin on Biomarkers for Insulin Resistance and Metabolic Syndrome in Patients with Polycystic Ovary Syndrome,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,left_only,,,,,,,,,,,,10.1177/193229680700100212,,,,,,,,,,,,,,,,19888409.0,,,,,,,,,
38,4,4.7,944,29,"Bahadur, Anupama, Hitanshi Arora, Anoosha K Ravi, Manisha Naithani, Yogesh Bahurupi, Jaya Chaturvedi, Megha Ajmani, and Rajlaxmi Mundhra. 2021. “Comparison of Clinical, Metabolic and Hormonal Effects of Metformin Versus Combined Therapy of Metformin With Myoinositol Plus D-Chiro-Inositol in Women With Polycystic Ovary Syndrome (PCOS): A Randomized Controlled Trial.” Cureus 13 (6): e15510. https://doi.org/10.7759/cureus.15510.
",primary_citation,,Bahadur,2021,"Bahadur et al., 2021",10.7759/cureus.15510,,,,,,"Comparison of Clinical, Metabolic and Hormonal Effects of Metformin Versus Combined Therapy of Metformin With Myoinositol Plus D-Chiro-Inositol in Women With Polycystic Ovary Syndrome (PCOS): A Randomized Controlled Trial",,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,left_only,,,,,,,,,,,,10.7759/cureus.15510,,,,,,,,,,,,,,,,34268040.0,,,,,,,,,
42,4,4.10.,1050,109,"Wang, F.; Dai, W.; Yang, X. H.; et al. (2016): Analyses of optimal body mass index for infertile patients with either polycystic or non-polycystic ovary syndrome during assisted reproductive treatment in China. Sci 6, 34538. https://dx.doi.org/10.1038/srep34538.",primary_citation,prior search,Wang,2016,"Wang et al., 2016",10.1038/srep34538,,,,,,Analyses of optimal body mass index for infertile patients with either polycystic or non-polycystic ovary syndrome during assisted reproductive treatment in China,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,left_only,,,,,,,,,,,,10.1038/srep34538,,,,,,,,,,,,,,,,27686055.0,,,,,,,,,
44,5,5.7.1,1238,7,"Kurzawa, R.; Ciepiela, P.; Baczkowski, T.; Safranow, K.; Brelik, P. Comparison of embryological and clinical outcome in GnRH antagonist vs. GnRH agonist protocols for in vitro fertilization in PCOS non‐obese patients. A prospective randomized study. J Assist Reprod Genet 2008, 25, 365‐74",primary_citation,,Kurzawa,2008,"Kurzawa et al., 2008",10.1007/s10815-008-9249-7,,,,,,Comparison of embryological and clinical outcome in GnRH antagonist vs. GnRH agonist protocols for in vitro fertilization in PCOS non-obese patients. A prospective randomized study,,,,,,,,,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,left_only,,,,,,,,,,,,10.1007/s10815-008-9249-7,,,,,,,,,,,,,,,,18802744.0,,,,,,,,,
